Abstract
Letters and Corrections1 July 1982Prognosis of Acute Myelogenous LeukemiaJUAN JOSÉ LAHUERTA-PALACIOS, SANTIAGO LARREGLA-GARRAUS, FRANCISCO FERNÁNDEZ-DEBORA, RICARDO RUIZ DE ADANAJUAN JOSÉ LAHUERTA-PALACIOSSearch for more papers by this author, SANTIAGO LARREGLA-GARRAUSSearch for more papers by this author, FRANCISCO FERNÁNDEZ-DEBORASearch for more papers by this author, RICARDO RUIZ DE ADANASearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-97-1-140_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Barton and Conrad reported in the February 1979 issue (1) an association of elevation of the aspartate transaminase (AST) levels with improved prognosis of acute myelogenous leukemia. Further data confirming this observation are scarce (2-4), although 2 years have elapsed since it was described.We wish to point out a critical defect in the studies that have been carried out: The AST level is considered to be the only factor that influences the prognosis. At the time of diagnosis and during the "induction phase" of acute myelogenous leukemia, there are additional simultaneous prognostic factors: classification, previous or...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
